Evidence map›Paper›PMID 36219487›Full record

ArticleMedical physics2022

A dedicated breast-PET/CT scanner: Numerical observer study of lesion detection.

Raymond R Raylman, Alexander Stolin, Savannah Hays, Evan Johnson, Sarah Lankas, Mahder Mekonnen, Kathryn Roemer

Open access · greenAbstract read
In one paragraph

Article in Medical physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Raymond R RaylmanDepartment of Radiology, School of Medicine, West Virginia University, Morgantown, West Virginia, USA.
Alexander StolinDepartment of Radiology, School of Medicine, West Virginia University, Morgantown, West Virginia, USA.
Savannah HaysDepartment of Chemical and Biomedical Engineering, Benjamin M. Statler College of Engineering and Mineral Resources, West Virginia University, Morgantown, West Virginia, USA.
Evan JohnsonDepartment of Chemical and Biomedical Engineering, Benjamin M. Statler College of Engineering and Mineral Resources, West Virginia University, Morgantown, West Virginia, USA.
Sarah LankasDepartment of Chemical and Biomedical Engineering, Benjamin M. Statler College of Engineering and Mineral Resources, West Virginia University, Morgantown, West Virginia, USA.
Mahder MekonnenDepartment of Chemical and Biomedical Engineering, Benjamin M. Statler College of Engineering and Mineral Resources, West Virginia University, Morgantown, West Virginia, USA.
Kathryn RoemerDepartment of Chemical and Biomedical Engineering, Benjamin M. Statler College of Engineering and Mineral Resources, West Virginia University, Morgantown, West Virginia, USA.
West Virginia University · US

Funding

Development of a PEM-PET-CT Breast Imaging and Biopsy DeviceR01CA094196 · NCI · WEST VIRGINIA UNIVERSITY · PI RAYLMAN, RAYMOND ROBERT · 2003 to 2013
$3.7M
A PET/CT scanner for guiding treatment of head and neck cancerR01CA248492 · NCI · WEST VIRGINIA UNIVERSITY · PI RAYLMAN, RAYMOND ROBERT · 2020 to 2025
$2.6M
PET-EPRIR01EB023888 · NIBIB · WEST VIRGINIA UNIVERSITY · PI RAYLMAN, RAYMOND ROBERT, TSEYTLIN, MARK · 2018 to 2021
$2.4M
NCI NIH HHS R01 CA094196NCI NIH HHS R01 CA248492NIBIB NIH HHS R01 EB023888
6 · The paper itself

Abstract

backgroundDedicated, breast-specific positron emission tomography (BPET)-cone-beam computed tomography (BPET/CT) systems have been developed to improve detection and diagnosis of cancer in women with indeterminate mammograms caused by radiodense breasts. The absorption of X-rays that often vexes mammography in this subset of women does not affect the detection of the high energy annihilation photons used in PET. PET imaging of the breast, however, is subject to limitations caused by their comparatively low spatial resolution (∼2 mm) and often moderate radiotracer uptake in lesions. PURPOSE: The purpose of this investigation is to explore the PET-based lesion detection capabilities of a BPET/CT scanner developed by the Department of Radiology Instrumentation group at West Virginia University.

methodsThe PET component of the system consists of a rotating pair of 96 × 72 arrays of 2 × 2 × 15 mm

resultsThe results showed that the smallest detectable lesion with this system is no smaller than ∼3 mm in diameter with a TBR of 6:1. Simulated lesions with diameters of 4 mm and greater were calculated to have good to excellent likelihood of detection for all TBRs tested.

conclusionThe results from this investigation identified the detectability capabilities and limitations for a dedicated breast-PET/CT scanner. Its ability to detect relatively small simulated FDG-avid breast lesions for a range of TBRs indicates its potential for clinical application. Finally, the study used methodologies that could be applied to a detectability assessment of other PET/CT scanners.

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyBreastFemaleHumansPhantoms, ImagingPositron-Emission TomographyTomography, X-Ray ComputedFluorodeoxyglucose F18breastCTnumerical observerPET

Identifiers

PMID36219487
PMCPMC9792429
OpenAlexW4304203222

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.